CLARENCE ADAMS: Open Payments
NPI 1609278290 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 2 payments from 2 companies in 2025. Trend: 2023 $79 · 2024 $52 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $100 |
Products named: CAPLYTA, INVEGA SUSTENNA.
Industry payments across CO — which companies pay providers there.
